摘要
肿瘤早期诊断对于选择合适的治疗方案至关重要,而单一模态磁共振成像(MRI)难以满足精确诊断的要求。本研究构建了聚丙烯酸(PAA)修饰的Fe_3O_4@MnO_2纳米粒子(Fe_3O_4@MnO_2@PAA)用于pH响应的T_1/T_2双模态MR成像,同时能够介导肿瘤的光热治疗。以Fe_3O_4为核,可以使Fe_3O_4@MnO_2@PAA纳米粒子在磁共振成像的T_2信号明显减低; MnO_2纳米壳在肿瘤内的酸性环境下可分解为顺磁性的Mn~(2+),能够增强T_1信号。这种pH响应的T_1/T_2双模态MRI造影剂具有良好的敏感性和特异性,可以为肿瘤诊断提供更全面、更详实的信息。此外,Fe_3O_4@MnO_2@PAA纳米粒子在近红外区表现出优异的吸收能力,可作为一种良好的光热转换材料介导肿瘤的光热治疗。这种pH响应的双模态磁共振成像介导光热治疗的新型纳米诊疗剂,在肿瘤的MRI诊断及光热治疗方面表现出良好的应用潜能。
The early accurate diagnosis is key to the successful treatment of tumours. However, single magnetic resonance imaging(MRI) mode cannot satisfy the high requirement of accurate diagnosis owing to their inherent defects. Herein, we constructed poly(acrylic) acid(PAA)-modified Fe_3O_4@MnO_2 nanoparticles(Fe_3O_4@MnO_2@PAA NPs) as a kind of pH-responsive T_1/T_2 dual-model MRI guiding photothermal therapy(PTT). Fe_3O_4 core enabled Fe_3O_4@MnO_2@PAA NPs to weaken T_2 signal in clinical MRI examination, and MnO_2 nanoshells were able to decompose into paramagnetic manganous ions under the weakly acidic environment of tumours, achieving pH-responsive T_1-weighted MRI. Such pH-responsive T_1/T_2 dual-model CAs with sensitivity and specificity provided more comprehensive information for diagnosis of tumours. Moreover, Fe_3O_4@MnO_2@PAA NPs exhibited excellent absorption in near-infrared(NIR) region, making them as good NIR photothermal agents for PTT. This work presented novel pH-responsive theranostic agents integrated dual-model imaging and PTT functionalities, and demonstrated their potential for stimuli-responsive MRI guided PTT of cancer.
引文
1 Jin X,Fang F,Liu J,Jiang C,Han X,Song Z,Chen J,Sun G,Lei H,Lu L.Nanoscale,2015,7(38):15680-15688
2 Burstein D,Velyvis J,Scott K T,Stock K W,Kim Y J,Jaramillo D,Boutin R D,Gray M L.Magn.Reson.Med.,2001,45(1):36-41
3 Wang S,Lin J,Wang Z,Zhou Z,Bai R,Lu N,Liu Y,Fu X,Jacobson O,Fan W,Qu J,Chen S,Wang T,Huang P,Chen X.Adv.Mater.,2017,29(35):1701013
4 Farnsworth R H,Lackmann M,Achen M G,Stacker S A.Oncogene,2014,33(27):3496-505
5 Kim R,Fieno D,Parrish T,Harris K,Chen E,Simonetti O,Bundy J,Finn J,Klocke F,Judd R.Circulation,1999,100(19):1992-2002
6 Leutz-Schmidt P,Stahl M,Sommerburg O,Eichinger M,Puderbach M,Schenk J,Alrajab A,Triphan S,Kauczor H,Mall M,Wielputz M.Eur.J.Radiol.,2018,101:178-183
7 Liu X,Jiang F,Wang Z,Li X,Li Z,Zhang X,Chen F,Mao J,Zhou L,Gui J.Sci.Rep.,2017,7(1):5395
8 Chen Y,Ye D,Wu M,Chen H,Zhang L,Shi J,Wang L.Adv.Mater.,2014,26(41):7019
9 Jin L,Liu J,Tang Y,Cao L,Zhang T,Yuan Q,Wang Y,Zhang H.ACS Appl.Mater.Interfaces,2017,9(48):41648-41658
10 Wang D,Zhou J,Shi R,Wu H,Chen R,Duan B,Xia G,Xu P,Wang H,Zhou S,Wang C,Wang H,Guo Z,Chen Q.Theranostics,2017,7(18):4605-4617
11 Mai B,Fernandes S,Balakrishnan P,Pellegrino T.Acc.Chem.Res.,2018,51(5):999-1013
12 Yang G,Zhang R,Liang C,Zhao H,Yi X,Shen S,Yang K,Cheng L,Liu Z.Small,2018,14(2):1702664
13 Wang Y,Song S,Liu J,Liu D,Zhang H.Angew.Chem.Int.Edit.,2015,127(2):546-550
14 Chen Q,Feng L,Liu J,Zhu W,Dong Z,Wu Y,Liu Z.Adv.Mater.,2016,28(33):7129-7136
15 Ding X,Liu J,Li J,Wang F,Wang Y,Song S,Zhang H.Chem.Sci.,2016,7(11):6695
16 Liu J,Jin L,Wang Y,Ding X,Zhang S T,Song S,Wang D,Zhang H.Small,2018,14(7):1702431
17 Zhou Z,Bai R,Munasinghe J,Shen Z,Nie L,Chen X.ACS Nano,2017,11(6):5227-5232
18 Gai S,Yang P,Li C,Wang W,Dai Y,Niu N,Lin J.Adv.Funct.Mater.,2010,20(7):1166-1172
19 Zhang L,Lian J,Wu L,Duan Z,Jiang J,Zhao L.Langmuir,2014,30(23):7006-7013
20 Yi X,Chen L,Zhong X,Gao R,Qian Y,Wu F,Song G,Chai Z,Liu Z,Yang K.Nano Res.,2016,9(11):3267-3278
21 Zhai Y,Zhai J,Zhou M,Dong S.J.Mater.Chem.,2009,19(38):7030-7035